Results 1 to 10 of about 401,106 (204)

Natural Killer Cells in Asthma [PDF]

open access: yesFrontiers in Immunology, 2013
The worldwide prevalence, morbidity, and mortality of asthma have dramatically increased over the last few decades and there is a clear need to identify new, effective, therapeutic and prophylactic strategies. Despite high numbers of NK cells in the lung
Khalil eKarimi, Paul eForsythe
doaj   +11 more sources

Uterine Natural Killer Cells [PDF]

open access: yesFrontiers in Immunology, 2019
Natural killer (NK) cells are members of a rapidly expanding family of innate lymphoid cells (ILCs). While most previously studied NK cells were derived from the mouse spleen and circulate in the blood, recently others and we found tissue-resident NK ...
Dorothy K. Sojka   +2 more
doaj   +4 more sources

Natural killer cells and natural killer T cells in Lyme arthritis [PDF]

open access: yesArthritis Research & Therapy, 2013
Introduction: Natural killer (NK) and natural killer T (NKT) cells provide a first line of defense against infection. However, these cells have not yet been examined in patients with Lyme arthritis, a late disease manifestation.
Drouin, Elise E   +2 more
core   +6 more sources

Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumors [PDF]

open access: yesMolecular Therapy: Oncology
Although adoptive natural killer cell therapies have been safe and somewhat effective in hematological malignancies, their performance in solid tumors is hindered by the solid tumor microenvironment, which impairs natural killer cell trafficking and ...
Shiori Eguchi   +5 more
doaj   +2 more sources

Purification and antibody-free ex-vivo expansion of peripheral blood-derived autologous natural killer cells: A Malaysian case series on patient safety and tolerability [PDF]

open access: yesSAGE Open Medical Case Reports
Natural killer cells are the most researched and employed cells for immunotherapy, which have expanded from autologous immune-enhanced therapies to genetically enhanced cell therapies such as chimeric antigen receptors natural killer cells.
Ramesh Thevendran   +2 more
doaj   +2 more sources

Natural killer cell neoplasms [PDF]

open access: yesCancer, 2008
AbstractNatural killer (NK) cell tumors are an uncommon and heterogeneous group of disorders. The World Health Organization (WHO) classified mature NK cell neoplasms into 2 types: 1) extranodal NK cell lymphoma, nasal type and 2) aggressive NK cell leukemia. The mature NK cell tumors are prevalent in Asia and Central and South America.
Xiayuan, Liang, Douglas K, Graham
openaire   +2 more sources

Reduced proportion and activity of natural killer cells in patients with Graves’ disease

open access: yesEuropean Journal of Inflammation, 2020
Natural killer cells not only play important roles in protecting against viral infection and cancer but also involved in the pathogenesis of Graves’ disease.
Qingqing Yang   +6 more
doaj   +1 more source

Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy [PDF]

open access: yesEinstein (São Paulo)
Natural Killer cells are immune leukocytes required for responses against tumor cells and virus-infected cells. In the last decade, natural killer cells have emerged as promising tools in cancer therapy, and clinical studies on patients treated with ...
Júlia Teixeira Cottas de Azevedo   +11 more
doaj   +1 more source

The activating receptors 2B4 and NTB-A, but not CRACC are subject to ligand-induced down-regulation on human natural killer cells [PDF]

open access: yes, 2010
Activation of natural killer cells can be mediated by different receptors. Stimulation of the receptors 2B4, NTB-A and CRACC, members of the SLAM-related receptor family, induces cytotoxicity and cytokine production.
Carolin Böhm   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy